Article Text

Download PDFPDF
Conjunctival squamous cell carcinoma: prognostic factors for the recurrence and metastasis and clinicopathological characteristics at an oncological hospital in Peru
  1. Deivy Cruzado-Sanchez1,
  2. Walter Andree Tellez2,
  3. Beltran Villarreal-Aguilar3,
  4. Monica Melendez1,
  5. Anibal Olivera1,
  6. Fiorella Moran1,
  7. Solon Serpas-Frias1,
  8. Raul Cordero-Garcia4
  1. 1Ophthalmic Oncology Service, Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima, Peru
  2. 2Sociedad Cientifica de estudiantes de medicina villarrrealinos (SOCEMVI), Unversidad Nacional Federico Villarreal (UNFV), Lima, Peru
  3. 3Sociedad científica de estudiantes de medicina de la Universidad Peruana de Ciencias Aplicada (SOCIEMUPC), Universidad Peruana de Ciencias Aplicadas (UPC), Lima, Peru
  4. 4Ophthalmic Oncology Service, Clinica Angloamericana, Lima, Peru
  1. Correspondence to Dr Deivy Cruzado-Sanchez, Ophthalmic oncology service, Intituto Nacional de Enfermedades Neoplasicas (INEN), Lima 15038, Peru; dcruzados{at}gmail.com

Abstract

Background/aims Conjunctival squamous cell carcinoma (CSCC) is the most frequent malignant tumour of the conjunctiva, with scarce recurrence and infrequent metastasis. The purpose of this study is to describe the clinical and pathological characteristics of this neoplasm and to identify the prognostic factors for recurrence and metastasis in a cancer hospital in Peru.

Materials and method A longitudinal, retrospective study of 176 consecutive patients diagnosed with SCC of the conjunctiva. Sociodemographic and clinical characteristics were evaluated. In addition, Kaplan-Meier curves were performed, and Cox regression was used to determine prognostic factors for recurrence and metastasis over time.

Result Only 12.5% presented tumour size ≤5 mm. The highest proportion according to the histopathological type was the well-differentiated infiltrative forms (40.9%), and according to tumour, node, metastases (TNM), stage T3 was the most frequent (31.3%). The most performed initial treatment was orbital exenteration (38.6%). The proportion of recurrence was 6.8% and 8.0% for metastasis. The annual survival rate was 7% and the annual metastasis rate was 6%; for recurrence after 5 years, the survival rate was 11% and the metastasis rate was 14%. No prognostic factor evaluated was significant.

Conclusion This is the most extensive patient study in Latin America with CSCC, with a high proportion of advanced histopathological grade, TNM stages, and radical treatments such as exenteration. Recurrence rates on average are similar to other reported studies, and it describes the rates of metastasis that have been poorly described in the literature.

  • neoplasia
  • ocular surface
  • conjunctiva
View Full Text

Statistics from Altmetric.com

Footnotes

  • Twitter @fiorellamoranz

  • Contributors DC-S have participated in the conception and design of the work. MM, AO, FM and SS-F have participated in the data extraction. DC-S and WAT have participated in the data analysis. All the authors participated in the interpretation of the data analysis. WAT wrote the initial draft of the manuscript.

  • Funding The study was self-funded.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Ethics approval The study was reviewed and approved by the ethical review board in biomedical research of the Universidad Peruana Cayetano Heredia (Approval code: 64274).

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data availability statement All data relevant to the study are included in the article or uploaded as supplementary information.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.